Skip to main content

Table 2 Clinical characteristics of study population

From: Cancer patients' attitudes towards Chinese medicine: a Hong Kong survey

Variables No. of patients
n(%)
Western medicine
n(%)
Chinese medicine n(%) P-value
Total 786(100.0) 337(42.9) 449(57.1)
Cancer type < 0.001
Lung 145(18.4) 46(13.6) 99(22.0)
Breast 128(16.3) 50(14.8) 78(17.4)
Prostate 22(2.8) 11(3.3) 11(2.4)
Colorectal 114(14.5) 53(15.7) 61(13.6)
Liver 13(1.7) 1(0.3) 12(2.7)
Stomach 15(1.9) 4(1.2) 11(2.4)
Nasopharyngeal 117(14.9) 45(13.4) 72(16.0)
Cervical 17(2.2) 12(3.6) 5(1.1)
Endometrial 23(2.9) 13(3.9) 10(2.2)
Ovary 18(2.3) 12(3.6) 6(1.3)
Other 174(22.1) 90(26.7) 84(18.7)
Stage (TNM) < 0.001
0-I 106(13.5) 56(16.6) 50(11.1)
II 122(15.5) 49(14.5) 73(16.3)
III 202(25.7) 71(21.1) 131(29.2)
IV 116(14.8) 35(10.4) 81(18.0)
Unknown 240(30.5) 126(37.5) 114(25.4)
Time since diagnosis (months) 0.005
36 537(68.3) 216(64.1) 321(71.5)
>36, 48 59(7.5) 23(6.8) 36(8.0)
>48, <60 27(3.4) 9(2.7) 18(4.0)
60 153(19.5) 81(24.0) 72(16.0)
Unknown 10(1.3) 8(2.4) 2(0.4)
  1. Data are presented as the actual number of patients (percentage in that group). Chi-square tests were conducted between Western medicine and Chinese medicine users.